| 000 | 01404 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517151232.0 | ||
| 264 | 0 | _c20180118 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdw674 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKessler, E R | |
| 245 | 0 | 0 |
_aPhase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _c03 2017 |
||
| 300 |
_a668 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment | ||
| 650 | 0 | 4 | _aAbiraterone Acetate |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPrednisone |
| 650 | 0 | 4 | _aProstatic Neoplasms |
| 650 | 0 | 4 | _aProstatic Neoplasms, Castration-Resistant |
| 650 | 0 | 4 | _aTaxoids |
| 700 | 1 | _aGao, D | |
| 700 | 1 | _aFlaig, T W | |
| 700 | 1 | _aBreaker, K | |
| 700 | 1 | _aWold, M | |
| 700 | 1 | _aWacker, M | |
| 700 | 1 | _aLam, E T | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 28 _gno. 3 _gp. 668 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdw674 _zAvailable from publisher's website |
| 999 |
_c27097021 _d27097021 |
||